|
(S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine |
|---|---|
| Trade Name | |
| Orphan Indication | Gastrointestinal stromal tumours |
| EU Market Approval | EU |
| EU Designation Date | 2017-07-17 00:00:00 |
| Sponsor | PhaRA bvba |
